Genus Capital Management’s Marvell Technology MRVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.5M Sell
35,250
-34,080
-49% -$6.83M 1.03% 30
2026
Q1
$6.87M Buy
69,330
+48,660
+235% +$4.09M 0.79% 44
2025
Q4
$1.76M Sell
20,670
-1,120
-5% -$98K 0.2% 109
2025
Q3
$1.83M Hold
21,790
0.21% 119
2025
Q2
$1.69M Sell
21,790
-10,360
-32% -$647K 0.21% 113
2025
Q1
$1.98M Buy
+32,150
New +$3.12M 0.29% 93

Other funds holding MRVL

Genus Capital Management's MRVL Position: Q2 2026 in Review

Genus Capital Management reduced its Marvell Technology (MRVL) stake by 49% in Q2 2026, selling an estimated $6.83M and leaving 35,250 shares worth $10.5M. The position accounts for 1.03% of the portfolio, ranked #30.

Genus Capital Management first reported a position in MRVL in Q1 2025 and has held it in 6 quarters since. 2,206 funds tracked by Wall St. Rank hold MRVL as of Q2 2026.

  • Genus Capital Management held 35,250 shares of Marvell Technology worth $10.5M as of Q2 2026.
  • Genus Capital Management sold 34,080 Marvell Technology shares in Q2 2026, an estimated $6.83M.
  • Marvell Technology made up 1.03% of Genus Capital Management's portfolio in Q2 2026, its #30 holding.
  • Genus Capital Management first reported a position in Marvell Technology in Q1 2025 and has held it in 6 quarters since.
  • 2,206 funds tracked by Wall St. Rank held Marvell Technology as of Q2 2026.

Based on Genus Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.